Conolidine’s analgesic effects stem from its conversation with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central nervous system, conolidine modulates alternate molecular targets. A Science Advances study identified that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://solanges197tww8.blogpixi.com/profile